Back
Sep 28
Poster Q & A
PQA 02 - Lung Cancer/Thoracic Malignancies, Patient Reported Outcomes/QoL/Survivorship, Pediatric Cancer
Presentations
-
04:45pm - 06:00pm PT
2-Hydroxyisobutyrylation of ALDH1A3 Promotes Stemness Maintenance and Radiotherapy Resistance in NSCLC via Activation of the STAT3 Signaling Pathway
Speaker: Zhiying Zhou, - Chongqing University, Chongqing -
04:45pm - 06:00pm PT
A Novel Imaging Biomarker for Radiation Induced Cardiotoxicity
Speaker: Arezoo Modiri, PhD - University of Maryland School of Medicine, Baltimore, Baltimore -
04:45pm - 06:00pm PT
A Phase II Trial of Safety and Efficacy of Radiotherapy Combined with Anlotinib in Locally Advanced Non-Small Cell Lung Cancer Patients Intolerable to Concurrent Chemoradiotherapy: Preliminary Surviva
Speaker: Yupei Yuan, MD - Cancer Hospital Chinese Academy of Medical Sciences, Beijing -
04:45pm - 06:00pm PT
A Pilot Study to Evaluate Percussive Ventilation Breath Hold to Improve Lung Stereotactic Ablative Radiotherapy (PVB-SABR)
Speaker: Wilson Mai, MD, PhD - Stanford University Cancer Center, Stanford -
04:45pm - 06:00pm PT
A Prospective, Phase II, Single-Arm Trial Evaluating Efficacy and Safety of the Regimen of Induction Cadonilimab plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Cadonilima
Speaker: Li CHU, - FUDAN UNIVERSITY SHANGHAI CANCER CENTER, SHANGHAI -
04:45pm - 06:00pm PT
A Prospective Study on the Predictive Value of the Modified Glasgow Prognostic Score in Non-Small Cell Lung Cancer Treated with Radiation Therapy
Speaker: Zhe Chen, MD, PhD - Yamanashi Prefectural Central Hospital, Kofu City -
04:45pm - 06:00pm PT
A Radiomics Method Based on Data Augmentation for Preoperative Prediction of Immature and Mature Teratoma
Speaker: Jing Yang, - Department of Radiation Oncology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, P.R. China., Hangzhou -
04:45pm - 06:00pm PT
A Temporal Perspective: Charting and Predicting Treatment Response in Breast Cancer-Related Lymphedema
Speaker: Encoh Yu, - Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto -
04:45pm - 06:00pm PT
Advancing Adaptive Radiotherapy with High-Fidelity CBCT-Based In-Situ Dose Calculation
Speaker: Shanti Marasini, PhD - Washington University in St. Louis School of Medicine, St Louis -
04:45pm - 06:00pm PT
Analyzing Major Depressive Disorder Risk Factors and Survival in Elderly GI Cancer Patients Using the SEER-MHOS Database
Speaker: Trudy Wu, MD, BS - University of California Los Angeles, Los Angeles -
04:45pm - 06:00pm PT
Arrythmias in Patients Receiving Thoracic Radiation
Speaker: Holly Grace, MD - UT Southwestern Medical Center, Dallas -
04:45pm - 06:00pm PT
Assessing Construct Validity of ESAS in Minority Populations and Exploring Temporal Variations in PROs by HPV Status Using PCA
Speaker: Shelly Sharma, MD - St. Jude Childrens Research Hospital, Memphis -
04:45pm - 06:00pm PT
Assessing Implementation of Electronic Patient-Reported Outcomes (ePRO) to Reduce Follow-Up Visits for Patients Undergoing Radiation Therapy for Breast Cancer
Speaker: Marco Santos Teles, BS - Rutgers New Jersey Medical School, Newark -
04:45pm - 06:00pm PT
Assessment of Baseline Financial Toxicity and Associated Social Determinants of Health among a Diverse Patient Population Undergoing Radiation Treatment
Speaker: Chaewon Hwang, MD - Tufts Medical Center | Beth Israel Deaconess Medical Center, Boston -
04:45pm - 06:00pm PT
Assessment of the Appropriateness of the Selection for Radiotherapy Intensity from a Quality of Life (EORTC QLQ-C30) Perspective in Older Cancer Patients
Speaker: Shigehiko Kuribayashi, MD, PhD - Tokyo Womens Medical University, Tokyo 162-8666 -
04:45pm - 06:00pm PT
Association between Geotemporal PM2.5 and Outcomes in Unresectable NSCLC Treated with Chemoradiotherapy
Speaker: Ansel Nalin, MD, PhD - MD Anderson Cancer Center, Houston -
04:45pm - 06:00pm PT
Associations between Heart Rate Elevation, Tachycardia and Cardiac Substructure Dose in Patients Receiving Chemoradiotherapy for Non-Small Cell Lung Cancer (NSCLC)
Speaker: Ali Ajdari, PhD - Massachusetts General Hospital, Boston -
04:45pm - 06:00pm PT
Automated Radiation Response Assessment with Deep Learning and Radiomics in Pediatric Diffuse Midline Glioma
Speaker: Reza Mojahed-Yazdi, MS - Brigham and womens hospital, Harvard Medical School, Boston -
04:45pm - 06:00pm PT
Balancing Quality of Life Considerations and Efficacy of Stereotactic Body Radiotherapy in Patients with Interstitial Lung Disease
Speaker: Simran Polce, MD - Moffitt Cancer Center, Tampa -
04:45pm - 06:00pm PT
Bayesian Model-Based Internal Target Volume Accounting for Interfractional Hilum Shifts during Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer
Speaker: Kazuhito Ueki, MD, PhD - Japan Radioisotope Association, Kobe -
04:45pm - 06:00pm PT
Begin with the End in Mind: Assessing Symptom Index for Patients with Prostate Cancer to Select the Right Bladder Protocol for Radiotherapy
Speaker: Zaheeda Mulla, RT - King Faisal Specialist Hospital and Research Centre, Riyadh -
04:45pm - 06:00pm PT
Biology-Guided Radiotherapy for Lung and Bone Tumors: Early Insights into Local Control Outcomes from the Prospective Premier Registry
Speaker: Tu Dan, MD - Thomas Jefferson University, Philadelphia -
04:45pm - 06:00pm PT
Biomarker Analysis of Iruplinalkib Combined with Chemoradiotherapy in ALK+ Unresectable Stage ? Non-Small Cell Lung Cancer
Speaker: Linlin Wang, MD, PhD - Shandong Cancer Hospital and Institute, Jinan -
04:45pm - 06:00pm PT
Bridging the Gap: Evaluating Patient Perceptions and Expectations of Radiation Therapy (PERT) Pre- and Post-Consultation
Speaker: Ari Kassardjian, MD - City of Hope Comprehensive Cancer Center, Duarte -
04:45pm - 06:00pm PT
Can Simulation CTs be Used to Identify and Intervene on Incidental Coronary Artery Disease in Patients with Breast Cancer?
Speaker: Kevin Chen, MD, MSCI - Washington University in St. Louis, St. Louis -
04:45pm - 06:00pm PT
Cardiac Risk, Outcomes, and Management among Older Adults with Stage I-II NSCLC Undergoing Stereotactic Body Radiation Therapy
Speaker: Leah Thompson, MD - Harvard Radiation Oncology Program, Boston -
04:45pm - 06:00pm PT
Cardiac Toxicity Following SBRT for Centrally Located Lung Tumors: Assessing the Impact of Radiation Dose Metrics
Speaker: James Shen, MD, PhD - Yale Therapeutic Radiology, New Haven -
04:45pm - 06:00pm PT
Cardioprotective Medications and the Incidence of Cardiovascular Events in Patients Treated with Radiotherapy: A Systematic Review and Meta-Analysis
Speaker: Vishwa Pakeerathan, MBBS - Princess Alexandra Hospital, Woolloongabba -
04:45pm - 06:00pm PT
Cardiovascular Outcomes Following Total Body Irradiation (TBI) in Children:A Systematic Review and Metanalysis
Speaker: Aahan Arif, MBBS - St. Jude Childrens Research Hospital, Memphis -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Chemoradiotherapy Integrated Tumor Cell Microparticles Elicit Ferroptosis and Immune Remodeling in Malignant Pleural Effusion
Speaker: Minqi Zhou, - Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan -
04:45pm - 06:00pm PT
Clinical and Dosimetric Predictors of Radiation Pneumonitis in Pathologic Stage III-N2 Non-Small Cell Lung Cancer Patients Receiving Postoperative Radiotherapy Following Lobectomy: An Analysis of a Pr
Speaker: Nengyang Wang, - Shanghai Chest Hospital Shanghai Jiao Tong University, Shanghai -
04:45pm - 06:00pm PT
Clinical and Pathological Characteristics of Exceptionally Young Patients with Multiple Primary Lung Cancers (ExY-MPLC) - Updated Data
Speaker: Xiaomin Zhang, - Department of Radiation Oncology, Peking University Shenzhen Hospital,Shen Zhen,China, Guangdong -
04:45pm - 06:00pm PT
Clinical Efficacy and Adverse Effects of Radiotherapy in Pediatric Medulloblastoma with Residual or Disseminated Disease - A Single Center Experience
Speaker: Xuejiao Shi, MD, PhD - Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, shanghai -
04:45pm - 06:00pm PT
Clinical Efficacy and Safety Evaluation of Radiotherapy/Chemoradiotherapy with or without Immunotherapy in Elderly Patients with Inoperable Locally Advanced Non-Small Cell Lung Cancer
Speaker: Yuhao Su, - The Fourth Hospital of Hebei Medical University, Shijiazhuang -
04:45pm - 06:00pm PT
Clinical Factors Associated with Urinary Morbidity in Men Undergoing Combination Prostate Radiation Therapy
Speaker: Benjamin Lee, MD - Urology of Greater Atlanta, Stockbridge -
04:45pm - 06:00pm PT
Clinical Features and Treatment Outcomes of Pediatric Abdominal and Pelvic Rhabdomyosarcoma
Speaker: Yuqing Wang, MD, PhD - Department of Radiation Oncology,Chongqing University Cancer Hospital, Chongqing -
04:45pm - 06:00pm PT
Clinical Outcomes of Neoadjuvant Chemoimmunotherapy vs. Neoadjuvant Chemoradiotherapy in the Treatment of Operable Non-Small Cell Lung Cancer
Speaker: Tal Sherman, MD - Drexel University College of Medicine, Philadelphia -
04:45pm - 06:00pm PT
Clinical Outcomes of Stereotactic Body Radiation Therapy (SBRT) for Centrally and Ultracentrally Located Early-Stage Lung Cancer
Speaker: Nikunj Patil, MD, MBBS - Kasturba Medical College, Manipal -
04:45pm - 06:00pm PT
Combining SBRT with GM-CSF and Peg-IFNa to Induce Abscopal Effects in Previously Treated Patients with Stage IV Thymic Tumors: A Prospective Study
Speaker: Min Fan, MD, PhD - Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai -
04:45pm - 06:00pm PT
Comparative Study of HEDOS and EDIC for Predicting 2-Year Survival in Locally Advanced NSCLC Patients Undergoing Radiotherapy
Speaker: Alessandra Catalano, - Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan -
04:45pm - 06:00pm PT
Comparison of Changes in Pulmonary Function after SBRT vs. Surgery for Early-Stage Non-Small Cell Lung Cancer: A Prospective Real-World Observational Study
Speaker: Yue Wang, - Tianjin Medical University Cancer Institute and Hospital, Tianjin -
04:45pm - 06:00pm PT
Comparison of Scanning Beam Proton Therapy vs. Photon IMRT in Patients with Locally Advanced Non-Small Cell Lung Cancer
Speaker: Model Zerfu, BS - University of Washington-Fred Hutchinson Cancer Center, Seattle -
04:45pm - 06:00pm PT
Comparison of the Efficacy of Immune Therapy Combined with Radiotherapy in Non-Gene-Sensitive Mutant NSCLC Brain Metastasis Patients: A Comparison of Whole-Brain Radiotherapy and Stereotactic Radiosur
Speaker: Erha Munai, - School of Medicine, Chongqing University, Chongqing, China, Chongqing -
04:45pm - 06:00pm PT
Concurrent Immunotherapy Improves Progression-Free Survival but Increases Toxicity in Unresectable Stage III NSCLC
Speaker: Dawei Chen, MD, MB - Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan -
04:45pm - 06:00pm PT
Contemporary Experience with Percutaneous High Dose Rate (HDR) Brachyablation for Malignant Lung Tumors
Speaker: Michelle Ann Eala, MD - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles -
04:45pm - 06:00pm PT
Cranial Radiotherapy Improves Survival in Brain Metastatic NSCLC Patients Bearing EGFR and TP53 Mutations
Speaker: LU WANG, MD, PhD - Department of radiotherapy oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, chongqing -
04:45pm - 06:00pm PT
Daily vs. Every-Other-Day Stereotactic Body Radiotherapy for Treatment of Ultra-Central and Central Non-Small Cell Lung Cancer
Speaker: Taylor Skelly, PharmD - University of Pittsburgh School of Medicine, Pittsburgh -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Delphi Consensus on Managing Non-Small Cell Lung Cancer (NSCLC) in Patients with Coexisting Interstitial Lung Disease
Speaker: Ahmed Salem, - Hashemite university, Zarqa -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Development and Validation of a Dynamic Nomogram for Predicting Brain Metastasis in Stage III NSCLC Patients Undergoing Definitive Chemoradiotherapy
Speaker: Xianyan Chen, MD, PhD - West China Hospital of Sichuan University, Chengdu -
04:45pm - 06:00pm PT
Development of a Time-Weighted Technique to Improve the Accuracy of Amplitude-Based 4D-CT in Lung Cancer Radiotherapy
Speaker: Jihyeon Joo, MD - Asan Medical Center, Seoul -
04:45pm - 06:00pm PT
Do Patients with Head and Neck Cancer Feel Anxious about Mask Use during Radiotherapy ? Importance of Medical Support and Coping Strategies
Speaker: Rachida Laraichi, - National Institute of Oncology, Budapest -
04:45pm - 06:00pm PT
Does Curative Radiotherapy Impact Fatigue Onset in Gynecological Cancer Patients? A 20-Year Single Institutional Experience in 501 Patients
Speaker: Paolo Bonome, MD - Gemelli Molise Hospital, Campobasso -
04:45pm - 06:00pm PT
Domain-Specific Quality-of-Life Outcomes in GI Malignancies: A Comparative Analysis of SBRT, PBT and IMRT
Speaker: Nikita Gupta, BS - Georgetown University School of Medicine, Potomac -
04:45pm - 06:00pm PT
Dosimetric Evaluation of Radiotherapy Planning Optimization Based on Cardiac Subvolumes in Patients with Lung Cancer
Speaker: H. Fazilet Dincbas, MD - Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Istanbul -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Durvalumab Concurrent and Following Thoracic Radiotherapy vs. Concurrent Chemoradiotherapy and Consolidation Durvalumab in Locally Advanced Non-Small Cell Lung Cancer: A Propensity Matched Analysis of
Speaker: Nikhil Mankuzhy, MD - Memorial Sloan Kettering Cancer Center, Middletown Township -
04:45pm - 06:00pm PT
Dynamic Change of Systemic Inflammatory Score in Predicting Survival of Patient with Unresectable Stage III Non-Small Cell Lung Cancer Treated by Definitive Chemoradiotherapy with or without Consolida
Speaker: Shihong Luo, MD - Cancer Hospital Chinese Academy of Medical Sciences, Beijing -
04:45pm - 06:00pm PT
Effects of Liberalizing Lung V5 on Intermediate and High-Dose Exposure: Insights from Lung and Esophageal Cases Treated with Photons
Speaker: Patrick Oh, MD - Yale School of Medicine, New Haven -
04:45pm - 06:00pm PT
Efficacy Analysis of Different Adjuvant Therapy Regimens in the Perioperative Period for Resectable Non-Small Cell Lung Cancer with Negative Driver Genes
Speaker: Jiarui Zhao, - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan -
04:45pm - 06:00pm PT
Efficacy and Safety of Hypofractionated Radiotherapy Plus Sequential Chemotherapy with Immunotherapy in Patients with Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer
Speaker: Yue Yu, - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing -
04:45pm - 06:00pm PT
Efficacy and Safety of Moderate-Dose SBRT for Patients with Oligometastatic Lung Cancer Ineligible for Standard SBRT
Speaker: Jongmoo Park, MD - Department of Radiation Oncology, School of Medicine, Kyungpook National University, Daegu -
04:45pm - 06:00pm PT
Efficacy and Safety of Oral Chemotherapy Concurrent Radiotherapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer after Neoadjuvant Chemoimmunotherapy
Speaker: Lei Deng, - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy, Beijing -
04:45pm - 06:00pm PT
Efficacy and Safety of Thoracic Radiotherapy in Untreated Metastatic Pulmonary Large-Cell Neuroendocrine Carcinoma: A Multicenter Retrospective Analysis
Speaker: Huiwen Yang, - Shandong Cancer Hospital, Jinan -
04:45pm - 06:00pm PT
Enhanced Survival in Stage IV NSCLC Patients: A Comparison of Sequential vs. Concurrent Radiotherapy Combined with Immunotherapy
Speaker: Yuqi Wang, - Shandong Provincial Key Laboratory of Precision Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical-Sciences, Jinan, Shandong,, Jinan -
04:45pm - 06:00pm PT
Enhancing Adverse Event Monitoring in Prostate Cancer Care with Large Language Models
Speaker: Monique Shotande, - Moffitt Cancer Research Center, Tampa -
04:45pm - 06:00pm PT
Esophageal Toxicity in Radical Radiotherapy Treatment of Malignant Pleural Mesothelioma
Speaker: Alberto Revelant, MD - CRO AVIANO, Aviano -
04:45pm - 06:00pm PT
Evaluating Outcomes in NSCLC Patients Receiving Amivantamab and Intracranial Radiation
Speaker: Nahid Howard, MS - Western University of Health Sciences, College of Osteopathic Medicine of the Pacific, Pomona -
04:45pm - 06:00pm PT
Evaluating [<sup>18</sup>F]Fluorodeoxyglucose (FDG) Uptake as a Prognostic Metric in Stage IV Lung Cancer Patients Being Treated with Pharmacological Ascorbate and Chemotherapy
Speaker: Ashley Way, MD - University of Iowa Hospitals & Clinics, Iowa City -
04:45pm - 06:00pm PT
Evaluating the Efficacy of Postoperative Radiotherapy in Thymoma Patients with Myasthenia Gravis
Speaker: Rongrong Zhou, MD, DO, PhD, BSN - Xiangya Hospital, Changsha -
04:45pm - 06:00pm PT
Evaluation of Cumulative Doses to Organs at Risk during Lung Reirradiation
Speaker: Navid Fallahi, MD - VCU Medical Center North Hospital - Massey Cancer Center, Richmond -
04:45pm - 06:00pm PT
Evaluation of Factors Affecting Radiological Changes and Treatment Response Following LUNG Stereotactic Ablative Radiotherapy
Speaker: Fazilet Dincbas, MD - Memorial Hospital, Chattanooga -
04:45pm - 06:00pm PT
Evaluation of Physical Activity, Biological Rhythm, and Eating Behavior in Cancer Patients Receiving Radiation Therapy
Speaker: Hatice Kubra Gunduz, MD - Marmara University Pendik Education and Research Hospital Radiation Oncology Clinic, Istanbul -
04:45pm - 06:00pm PT
Examining the Relationship between Cumulative Radiotherapy Dose to the Nipple-Areolar Complex and Breast Sensorisexual Function
Speaker: Amarachi Okorom, BA - Icahn School of Medicine at Mount Sinai, Bronx -
04:45pm - 06:00pm PT
Examining Treatment and Outcome Disparities in Lung Cancer Among Northern Plains American Indians and Non-Indigenous Populations
Speaker: Peter Wilson, MD - University of Minnesota, Minneapolis -
04:45pm - 06:00pm PT
Exploration on Perioperative Treatment Strategies of Driver Gene-Positive Resectable Non-Small Cell Lung Cancer
Speaker: Xingpeng Wang, - School of Clinical Medicine, Shandong Second Medical University, Jinan -
04:45pm - 06:00pm PT
Exploratory Study on the Impact of Intestinal Low-Dose Radiation on the Efficacy and Prognosis of Immunotherapy in Metastatic Non-Small Cell Lung Cancer
Speaker: Baiyang Huang, - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China, Jinan -
04:45pm - 06:00pm PT
Factors Associated with Prostate Cancer Survivors Engagement in the Community, Results from a Population-Based Cohort
Speaker: Shelby Watts, BS - University of Kansas, Lawrence -
04:45pm - 06:00pm PT
FGFR3 Mediates Radioresistance in Non-Small Cell Lung Cancer through Reprogramming of Fatty Acid Metabolism
Speaker: Ran Zhang, PhD - Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan -
04:45pm - 06:00pm PT
Fifteen-Year Trends in Single-Fraction SBRT Utilization for Stage I Non-Small Cell Lung Cancer
Speaker: Drew Moghanaki, MD, MPH - VA Greater Los Angeles, Los Angeles -
04:45pm - 06:00pm PT
Financial Distress Does Not Increase after Radiation Therapy: Analysis of Change in COST Score before and after Radiation Therapy
Speaker: Samyak Badkul, BS - Kansas Health Science Center, Wichita -
04:45pm - 06:00pm PT
Financial Stress and Cost-Coping Behaviors Associated with Financial Toxicity among a Diverse Patient Population Undergoing Radiation Treatment
Speaker: Kian Sahani, BS - Beth Israel Deaconess Medical Center, Boston -
04:45pm - 06:00pm PT
Financial Toxicity in Patients with Sarcoma Undergoing Radiation Therapy
Speaker: Rachel Zhang, - University of California Irvine School of Medicine, Irvine -
04:45pm - 06:00pm PT
Functional Outcome Evaluation of Gamma Knife Stereotactic Radiosurgery Treatment for Essential and Parkinsonian Tremor - A Private Institution Evaluation
Speaker: Daniele Dunham, - Tacoma Valley Radiation Oncology, Tacoma -
04:45pm - 06:00pm PT
Genomic Predictors of Brain Metastases in Non-Small Cell Lung Cancer: Implications for Early Detection and Targeted Surveillance
Speaker: Victor Lee, MD, BS - Yale New Haven Hospital, Middletown -
04:45pm - 06:00pm PT
Geriatric Assessment among Vulnerable Older Adults Undergoing Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
Speaker: Sarah Lipson, - Harvard Medical School, Boston -
04:45pm - 06:00pm PT
Harnessing Lactate-Efflux Inhibition to Sensitize Radiotherapy: A Metabolic-Immune Dual-Targeting Strategy for NSCLC
Speaker: Wenqian Yuan, - Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan -
04:45pm - 06:00pm PT
High PD-L1 Expression is Associated with Adaptive Replanning in Patients with Locally Advanced (LA) Non-Small Cell Lung Carcinoma (NSCLC) Treated with Chemoradiotherapy (chemoRT)
Speaker: Jennifer Zagelbaum, - Harvard Radiation Oncology Program, Boston -
04:45pm - 06:00pm PT
Higher Baseline Monocyte and Neutrophil Counts Are Associated with Significantly Worse Overall Survival in NSCLC Patients Treated with Curative-Intent Chemoradiation
Speaker: Philippa Johnstone, MBBS - Peter MacCallum Cancer Centre, Melbourne -
04:45pm - 06:00pm PT
High-Risk Carotid Artery Ultrasound Findings in Head and Neck Cancer Survivors after Radiation Therapy: Results of a Prospective Study
Speaker: Ryan Hughes, MD - Wake Forest University School of Medicine, Winston Salem -
04:45pm - 06:00pm PT
Hyperfractionated Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer: A Retrospective Study
Speaker: Wei Zhou, MD, BS - Chongqing Cancer Hospital, Chongqing -
04:45pm - 06:00pm PT
Hypofractionated Radiotherapy Sequenced with Immuno-Chemotherapy for Limited-Stage Small-Cell Lung Cancer
Speaker: Kunpeng Xu, MD - Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical , Shenzhen -
04:45pm - 06:00pm PT
Identification of Dosimetric and Clinical Predictors for Post-Treatment Pulmonary Hospitalizations in NSCLC
Speaker: Josiah Nieto, MD - University of Michigan, Ann Arbor -
04:45pm - 06:00pm PT
Identification of Radioresistance Biomarkers Using Surface-Enhanced Raman Scattering (SERS) Molecular Diagnosis and Multi-Omics in NSCLC Cells
Speaker: Nan Li, MD - Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing, China, Chongqing -
04:45pm - 06:00pm PT
Imaging and Clinical Outcomes Following Definitive Radiation Therapy for Children with High-Grade Glioma
Speaker: Soumya Unnikrishnan, MD, MS - Winship Cancer Institute of Emory University, Atlanta -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Impact of Hepatic Radiotherapy on Survival Outcomes in Small Cell Lung Cancer Patients with Liver Metastases: A Retrospective Study
Speaker: Xiangjiao Meng, - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan -
04:45pm - 06:00pm PT
Impact of Household Income on Symptom Burden and Quality of Life in Long-Term Head and Neck Cancer Survivors
Speaker: Reagan Andersen, BS - The University of Alabama at Birmingham, Birmingham -
04:45pm - 06:00pm PT
Impact of Lung Dose on Pulmonary Function Decline after Stereotactic Body Radiation Therapy for Lung Cancer
Speaker: Hidekazu Tanaka, MD, PhD - Yamaguchi University Graduate School of Medicine, Ube -
04:45pm - 06:00pm PT
Impact of PDL-1 Expression on Long Term Disease Outcomes in Unresectable Locally Advanced Non-Small-Cell Lung Cancer Treated with Chemoradiation with or without Immunotherapy
Speaker: Charvi Shah, BS - Rutgers Robert Wood Johnson Medical School, New Brunswick -
04:45pm - 06:00pm PT
Impact of Prolonged Overall Treatment Time on Prognosis in Patients with Limited-Stage Small-Cell Lung Cancer Treated with Definitive Chemoradiotherapy
Speaker: Miki Kajima, MD - Yamaguchi University Graduate School of Medicine, Ube -
04:45pm - 06:00pm PT
Impact of Radiotherapy on Fatigue in Prostate Cancer Patients: An Analysis of 1253 Patients
Speaker: Paolo Bonome, MD - Gemelli Molise Hospital, Campobasso -
04:45pm - 06:00pm PT
Impact of Radiotherapy-to-Tyrosine Kinase Inhibitor Sequence and Time-Interval on Pneumonitis and Treatment Discontinuation in EGFR/ALK-Mutated Non-Small Cell Lung Cancer
Speaker: Andrea Brown, MD - Johns Hopkins Radiation Oncology Kimmel Cancer Center, Baltimore -
04:45pm - 06:00pm PT
Impact of Smoking Status on Survival and Radiation-Induced Toxicity in Lung Cancer Patients Receiving Radiotherapy: A Retrospective Cohort Study
Speaker: Julia Pavão, - 1. RadioSerra Radiation Therapy 2. Petropolis Medical School - FMP, Petrópolis -
04:45pm - 06:00pm PT
Impact of Socioeconomic Disadvantage on Quality of Life Changes at End of Radiotherapy
Speaker: Kaina Chen, MS - Boston University, Boston -
04:45pm - 06:00pm PT
Impact of Systematic Invasive Mediastinal Staging on Recurrence Rates Following SBRT for Early-Stage NSCLC
Speaker: Rachel Fisher, MS, BS - University of Arizona College of Medicine - Phoenix, Phoenix -
04:45pm - 06:00pm PT
Individual Participant Data Meta-Analysis (IPDMA) and Systematic Review of Radical Radiotherapy in Oligometastatic Non Small Cell Lung Carcinoma (NSCLC)
Speaker: Ajay Kumar Kondeti, MD - All India Institute of Medical Sciences, Mangalagiri, VIJAYAWADA -
04:45pm - 06:00pm PT
Induction Chemotherapy Administration Increases the Risk of Radiation Pneumonitis in Unresectable Stage III NSCLC Patients Undergoing Concurrent Chemoradiotherapy with Immunotherapy
Speaker: Pengwei Li, - Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan -
04:45pm - 06:00pm PT
Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer
Speaker: Yaping Xu, PhD - Shanghai Pulmonary Hospital, Shanghai -
04:45pm - 06:00pm PT
In-Field Progression Rates Following Concurrent Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer: A Systematic Review
Speaker: Shannon Nesbit, BS - Department of Radiation Oncology, University of California, Los Angeles, Los Angeles -
04:45pm - 06:00pm PT
Integrating Deep and Reinforcement Learning for Detection and Segmentation of Lung Metastases from Adenoid Cystic Carcinoma (ACC) in Chest CT Scans
Speaker: Sang Kyun Yoo, PhD, BS - Yonsei Cancer Center, Yonsei University College of Medicine, Seoul -
04:45pm - 06:00pm PT
Integration of Serum Metabolomics, MRI Radiomics, and Clinical Parameters for Predicting Long-Term Post-Radiotherapy Trismus in Nasopharyngeal Carcinoma: A Tri-Modal Modeling Approach
Speaker: Lei Ji, MD - The First Affiliated Hospital of Soochow University, Soochow -
04:45pm - 06:00pm PT
Intentional Protection of the Contralateral Esophagus in Thoracic Radiotherapy for Lung Cancer
Speaker: Jia-Qi Huang, - Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai -
04:45pm - 06:00pm PT
Irradiation-Induced CK2/SUPT16H Axis Modulation Enhances Radiation Resistance in Lung Cancer via DNA Damage Response and Chromatin Remodeling
Speaker: Rui Meng, PhD - Department of Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan -
04:45pm - 06:00pm PT
KEAP1/NRF2 Mutation Phenotype Predicts Local Control in Early-Stage Lung Cancer Patients Treated with Stereotactic Ablative Radiotherapy
Speaker: Noah Kastelowitz, MD, PhD - Stanford University School of Medicine, San Jose -
04:45pm - 06:00pm PT
Knockdown of AKR1C1 Enhances NEDD4-Mediated Ubiquitination of GPX4 to Promote Ferroptosis and Radiosensitization in Non-Small Cell Lung Cancer
Speaker: Weiwei Yan, - Shandong Cancer Hospital Affiliated to Shandong University, Jinan -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
LncRNA SNHG17/IGF2BP1/AURKA Axis Promotes Radiation Resistance in Non Small-Cell Lung Cancer by Regulating Autophagy
Speaker: Fengti Chen, - Department of Radiation Oncology, The Second Affiliated Hospital of Guangxi Medical University, Nanning -
04:45pm - 06:00pm PT
Local Control Efficacy of Radiotherapy and Prognostic Factors in Pancreatoblastoma: A Single-Center Experience with a Rare Pediatric Tumor
Speaker: Qi Wang, PhD - Shandong Cancer Hospital, Shandong Provincial Key Medical and Health Laboratory of Pediatric Cancer Precision Radiotherapy, Ji Nan -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Low-Dose Radiotherapy Enhances the Antitumor Immunity of ISABR in Non-Small Cell Lung Cancer
Speaker: Ziye Li, - Department of Radiation Oncology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei -
04:45pm - 06:00pm PT
Lung V5 and Post-Radiation Lymphopenia as Predictors of Symptomatic Radiation Pneumonitis in Real-World Lung Cancer Patients in China: A Retrospective Analysis
Speaker: Qianqian Lei, MD - Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing -
04:45pm - 06:00pm PT
Machine Learning Empowered Precise Prediction for Patient Severe Symptoms and Outcomes Undergoing Radiotherapy: Less Is More Philosophy Using Multi-Class Classifiers and Semi-Supervised Anomaly Detect
Speaker: Zhong Chen, - School of Computing, Southern Illinois University, Carbondale -
04:45pm - 06:00pm PT
Magnetic Resonance Can be Used in Guiding Hypo-Fractionated Radiotherapy for Non-Small Cell Lung Cancer
Speaker: Ligang Xing, - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China, Jinan -
04:45pm - 06:00pm PT
MGLL-Driven Ferroptosis Via ATG9A-Mediated Lipid Mobilization Enhances Radiosensitivity in NSCLC
Speaker: Yujiao Ma, - Shandong university, Jinan -
04:45pm - 06:00pm PT
Molecular Markers in Lung Cancer as a Predictor of Response to SBRT
Speaker: Rakhi Kaila, MD - Detroit Medical Center, Detroit -
04:45pm - 06:00pm PT
Monocyte-Macrophage Modulation in Radiation-Immunotherapy-Induced Pneumonitis in NSCLC
Speaker: Qian Zhao, MD, PhD - Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan -
04:45pm - 06:00pm PT
MR vs CT-Based Cardiac Delineation in Pediatric Patients with Hodgkin Lymphoma
Speaker: Sidharth Ramesh, MD - Hospital of the University of Pennsylvania, Philadelphia -
04:45pm - 06:00pm PT
MTA3-Driven Glutamine Synthetase Upregulation as a Mechanism for Radiosensitivity Regulation in Non-Small Cell Lung Cancer
Speaker: Liang Du, PhD - Chongqing University Cancer Hospital, Chongqing -
04:45pm - 06:00pm PT
Multidisciplinary Team (MDT) Perceptions Towards the Treatment of Limited-Stage Small-Cell Lung Cancer (LS-SCLC): A US Physician Survey
Speaker: Rebeca Mora, - AstraZeneca, Noblesville -
04:45pm - 06:00pm PT
Neuroanatomical Structural Changes in Irradiated Survivors of Craniopharyngioma: A Secondary Analysis of RT3CR
Speaker: Aahan Arif, MBBS - St. Jude Childrens Research Hospital, Memphis -
04:45pm - 06:00pm PT
Nutrition-Related Hematological and Body Composition Biomarkers in Stage III Unresectable NSCLC Treated with Immunochemoradiotherapy: A Retrospective Cohort Study
Speaker: Xia Gan, MBBS - Hunan Cancer Hospital, Changsha -
04:45pm - 06:00pm PT
Off-Protocol Radiotherapy in Prospective Systemic Therapy Trials for Metastatic Non-Small Cell Lung Cancer
Speaker: Kara Ruicci, MD, PhD - University of Toronto, -
04:45pm - 06:00pm PT
OIP5 Mediates Radiotherapy Resistance in Lung Adenocarcinoma through POLD1-Dependent DNA Damage Repair
Speaker: Siwei Zeng, - Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing -
04:45pm - 06:00pm PT
Optimizing Chemoradiotherapy for Small Cell Lung Cancer in the Immunotherapy Era
Speaker: Travis Lambert, MD - Montefiore Medical Center/Albert Einstein College of Medicine, Bronx -
04:45pm - 06:00pm PT
Optimizing Fractionation Strategies for Early-Stage NSCLC: Real-World Toxicity and Outcomes from a Statewide Consortium
Speaker: Luke Higgins, MD - University of Michigan, Ann Arbor -
04:45pm - 06:00pm PT
Outcomes and Toxicity of 60 Gy in 8 Fractions Stereotactic Body Radiotherapy to Peripheral Tumors Adjacent to the Chest Wall: A Single Institution Experience
Speaker: Tala Mobayed, MD - American University of Beirut Medical Center, Beirut -
04:45pm - 06:00pm PT
Outcomes and Treatment Patterns in Pediatric Head and Neck Rhabdomyosarcoma: A Retrospective Study of 105 Patients
Speaker: Mohammed Qamber, MD - Bahrain Oncology Center, Muharraq -
04:45pm - 06:00pm PT
Outcomes Following Proton Radiation for Pediatric Meningiomas
Speaker: Elizabeth Thompson, MD - Department of Radiation Oncology, University of Florida College of Medicine, Gainesville -
04:45pm - 06:00pm PT
Outcomes of Patients with Intracranial Germinoma Enrolled on the Pediatric Proton Photon Consortium Registry
Speaker: Elaine Cha, MD - MD Anderson Cancer Center, Houston -
04:45pm - 06:00pm PT
Outcomes of Single-Fraction Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: A Multi-Institution Population-Based Study
Speaker: Jose Miguel Callueng, MD - BC Cancer Agency - Kelowna, Kelowna -
04:45pm - 06:00pm PT
Patient Reported Outcomes (PROs) after Radiation Therapy or Surgery followed by Radiation Therapy for Prostate Cancer
Speaker: Muhammad Shuja, MD - Mayo Clinic, Rochester -
04:45pm - 06:00pm PT
Patient-Reported Outcomes (PROs) in Prostate Cancer Patients Undergoing IMRT vs. IMRT with Brachytherapy
Speaker: Emily Hanus, - University of Kansas Medical Center, Kansas City -
04:45pm - 06:00pm PT
Patterns of Failure and Toxicity in Patients with N2 vs. N3 Disease Undergoing Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer
Speaker: Melanie Berger, MD - Hospital of the University of Pennsylvania, Philadelphia -
04:45pm - 06:00pm PT
Patterns of Failure for Patients with Thymoma Treated with Post Operative Radiation Therapy
Speaker: Oded Icht, MD, MBA - Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto -
04:45pm - 06:00pm PT
Phenotyping Chronological Accumulation of Comorbidities for Prostate Cancer Patients: A Computational Approach
Speaker: Matthew Kim, BS - University of California, San Francisco, San Francisco -
04:45pm - 06:00pm PT
PIK3CD Affect Radiotherapy Resistance in LUAD Cells by Reprogramming Lipid Metabolism through PI3K/AKT Pathway
Speaker: Yingze Ma, MB - Shandong Cancer Hospital and Institute, Jinan -
04:45pm - 06:00pm PT
Portrayal of Radiation Therapy in North American TV Shows
Speaker: Elsa Sutton, MD - Mayo Clinic Rochester, Rochester -
04:45pm - 06:00pm PT
Post Radiotherapy Lymphocyte Dynamics and Dose Constraints in Locally Advanced Thoracic Malignancies Undergoing Radical Radiotherapy
Speaker: Ben Man Fei Cheung, MD - Queen Mary Hospital, Hong Kong -
04:45pm - 06:00pm PT
Postmarketing Surveillance of Adverse Events after Immune Checkpoint Inhibitor Therapy and Radiotherapy
Speaker: Qian Zhang, MD, PhD, MS - McGaw Medical Center of Northwestern University, Chicago -
04:45pm - 06:00pm PT
Postoperative Radiotherapy in Surgically Resected Pathologic N2 Non-Small Cell Lung Cancer Post-Chemotherapy: A Multicenter Study
Speaker: Zeliang Ma, MD - Mayo Clinic Rochester, Rochester -
04:45pm - 06:00pm PT
Practice Variations and Outcomes of Definitive Radiation for Non-Metastatic NSCLC following Induction Chemoimmunotherapy
Speaker: Troy Kleber, MD, MS - MD Anderson Cancer Center, Houston -
04:45pm - 06:00pm PT
Predicting Decreased Quality of Life in Cancer Survivors Undergoing Radiotherapy Using a Random Forest Model
Speaker: Meimei Shang, - Shandong Cancer Hospital and Institute, Shandong First University, Jinan -
04:45pm - 06:00pm PT
Prediction of Esophagitis following Intensity-Modulated Radiotherapy for Lung Cancer Using Statistical and Machine Learning Methods
Speaker: Nathaniel Miller, MD, BS - VCU School of Medicine, Richmond -
04:45pm - 06:00pm PT
Prediction of Oligometastatic Disease from Breast Cancer Using Next Generation Sequencing Genomics
Speaker: Patrick Young, DO - Atrium Health Wake Forest Baptist, Lexington -
04:45pm - 06:00pm PT
Predictive Risk Factors for Radiation Retinopathy in Eye Brachytherapy
Speaker: David Reichstein, MD - Tennessee Retina, Nashville -
04:45pm - 06:00pm PT
Preparation of mRNA-LNP Vaccine Based on HER2 Target and Its Antitumor Effect in Combination with Radiotherapy in Lung Cancer
Speaker: Jun Wang, MD, PhD - Fourth Hospital of Hebei Medical University, Shijiazhuang -
04:45pm - 06:00pm PT
Primary Lesion-Directed Stereotactic Body Radiotherapy for Advanced Non-Small Cell Lung Cancer Treated with First-Line Systemic Therapy
Speaker: Dan Tao, MD - Chongqing University Cancer Hospital, Chongqing -
04:45pm - 06:00pm PT
Prognostic Value and Immunological Correlation of Spleen Volume Change in Extensive-Stage Small-Cell Lung Cancer Treated with Chemo-Immunotherapy
Speaker: Xiuli Liu, - Department of Radiation Oncology, Shandong Cancer Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China, Jinan -
04:45pm - 06:00pm PT
Promise of LET-Optimized Intensity Modulated and Arc Proton Therapy for Pediatric Rhabdomyosarcoma: A Multi-Patient Comparative Dosimetry Study
Speaker: Daniel Indelicato, MD, FASTRO - University of Florida Department of Radiation Oncology, Jacksonville -
04:45pm - 06:00pm PT
Prophylactic Cranial Irradiation in Resected Early Stage Small Cell Lung Cancer: An Updated Systematic Review and Meta-Analysis
Speaker: Ze Yuan, MD - Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing -
04:45pm - 06:00pm PT
Prospective Patient-Reported Outcomes (PRO) Regarding Skin Toxicity from Hypo-Fractionated Regional Nodal Irradiation (RNI) following Mastectomy and Lumpectomy
Speaker: Sunitha Varghese, MD, MBBS - The University of Kansas Health System, Kansas city -
04:45pm - 06:00pm PT
Prospective Validation of a Pretreatment 18F FDG PET CT plus Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Chemoradia
Speaker: Maria Thor, PhD, MS - Memorial Sloan Kettering Cancer Center, New York -
04:45pm - 06:00pm PT
Proton Therapy for Hemithoracic Pleural Irradiation: A Step Toward Safer Radiation Treatment
Speaker: Drishti Panse, MD, BS - Mount Sinai, New York -
04:45pm - 06:00pm PT
Proton Therapy for Pediatric Patients with Localized Unresectable Osteosarcoma
Speaker: Daniel Indelicato, MD, FASTRO - University of Florida Department of Radiation Oncology, Jacksonville -
04:45pm - 06:00pm PT
Proton Therapy in Pediatric Craniopharyngioma: Comparison between Adjuvant and Salvage Radiotherapy Efficacy and Toxicity
Speaker: Ory Haisraely, MD, MPH - MD Anderson Cancer Center, Houston -
04:45pm - 06:00pm PT
Quality-of-life Metrics Correlate with Dual-energy and 4D CT Derived Perfusion and Ventilation In Lung Cancer Patients 6 months Post Radiation Therapy
Speaker: Maksym Sharma, PhD - University of Pennsylvania, Philadelphia -
04:45pm - 06:00pm PT
Quantifying Radiation-Induced Pulmonary Fibrosis: A Novel CT-Based Approach to Measuring Lung Scarring After SBRT
Speaker: Alex Sachelarie, - University of California, Berkeley, Berkeley -
04:45pm - 06:00pm PT
Radiation Oncology at the Interface of Pediatric Cancer Biology and Data Science
Speaker: David Kozono, MD, PhD - Dana-Farber Brigham Cancer Center, Boston -
04:45pm - 06:00pm PT
Radiomic Analysis for Prediction of Progression Free Survival and Early Polymetastatic Progression in Lung Oligometastases Patients on SABR-5 Trial
Speaker: Tenzin Kunkyab, PhD - The Mount Sinai Hospital, New York -
04:45pm - 06:00pm PT
Radiomics Analysis in SBRT for Pulmonary Oligometastases: The Potential of Peritumoral Features in Predicting Treatment Response
Speaker: Yao Lu, - 1. Department of Radiation Oncology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, P.R. China. 2. Department of Health Technology and Informatics, T, Hangzhou -
04:45pm - 06:00pm PT
Radiosurgery for Pediatric Central Nervous System Lesions ? Initial Report and Insights from a Multicenter Registry
Speaker: Felix Ehret, MD - Massachusetts General Hospital, Boston -
04:45pm - 06:00pm PT
Randomization in Oligoprogressive Disease: Can We Still Run Trials, or Have We Lost Equipoise?
Speaker: Emily Boyer, MD - University of Ottawa, Ottawa -
04:45pm - 06:00pm PT
Rates of Fertility/Hormonal Preservation among Locally Advanced Cervical Cancer Patients Treated with Definitive Chemoradiation and Brachytherapy
Speaker: Stella Lymberis, MD - New York University Cancer Center, New York -
04:45pm - 06:00pm PT
Real World Radiographic Response Rates and Pre-Operative Attrition in Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Neoadjuvant Chemoimmunotherapy
Speaker: Cole Friedes, MD - University of Pennsylvania, Philadelphia -
04:45pm - 06:00pm PT
Real-World Data of Radiotherapy Induced Hypothyroidism in Head and Neck Cancer Patients
Speaker: Hao-Shen Cheng, MD - Taichung Veterans General Hospital, Taichung -
04:45pm - 06:00pm PT
Real-World Outcomes of Single-Fraction Stereotactic Ablative Radiotherapy (SF-SABR) for Oligo-Persistent, Progressive, or Recurrent Primary and Metastatic Lung Tumors
Speaker: Wei-Chieh Huang, MD - Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, Taipei -
04:45pm - 06:00pm PT
Real-World Study on the Efficacy, Safety, and Prognostic Analysis of Chemotherapy Combined with Immunotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer
Speaker: Jun Wang, MD, PhD - Fourth Hospital of Hebei Medical University, Shijiazhuang -
04:45pm - 06:00pm PT
Refining SBRT for Ultra-Central NSCLC: Non-Uniform PTV and Strict OAR Constraints for Optimal Control and Minimal Toxicity
Speaker: Yaping Xu, PhD - Shanghai Pulmonary Hospital, Shanghai -
04:45pm - 06:00pm PT
Reirradiation for Pediatric Central Nervous System Tumors: Validation of an LQ Model-Based Approach for Critical Structure Dose Constraints and Clinical Outcomes
Speaker: Natalia Martynova, MD - Dr. Berezin Medical Institute, Saint-Petersburg -
04:45pm - 06:00pm PT
Reirradiation or Repeat Organ Irradiation for Non-Small Cell Lung Cancer: Oncological Outcomes and Toxicities
Speaker: Jonas Willmann, MD - University Hospital Zurich, Kilchberg -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Retrospective Study of the Efficacy and Safety of Lung Malignancy Radiation In-Field of Prior Ipsilateral Breast Radiation
Speaker: Mary-Kate Lawlor, MD - Yale New Haven Health, New Haven -
04:45pm - 06:00pm PT
Risk of Cardiac Toxicity Influences Treatment Decisions in Lung Cancer: A National Survey
Speaker: Erik Blomain, MD, PhD - Thomas Jefferson University, Philadelphia -
04:45pm - 06:00pm PT
Role of Parotid Glands in Mediating Taste-Smell Connection in Patients with Nasopharyngeal Carcinoma: Results of A Phase 2 Clinical Trial
Speaker: Annie Chan, MD - Massachusetts General Hospital, Boston -
04:45pm - 06:00pm PT
Role of Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer Patients with Bone Metastases: A Multicenter Retrospective Analysis
Speaker: Xinyu Fan, - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan -
04:45pm - 06:00pm PT
Safety and Activity of KRAS G12C Inhibitors Combined with Thoracic Radiation Therapy
Speaker: Helen Zhang, MD - Memorial Sloan Kettering Cancer Center, New York -
04:45pm - 06:00pm PT
Safety and Efficacy of Lung Stereotactic Body Radiation Therapy for Surgical Staple Line Recurrences
Speaker: Katie Scharf, MD - Rush University Medical Center, Chicago -
04:45pm - 06:00pm PT
Safety and efficacy of photon re-irradiation with whole brain radiotherapy or craniospinal irradiation for recurrent pediatric central nervous system malignancies
Speaker: Palak Patel, MD, BS - Massachusetts General Brigham, Boston -
04:45pm - 06:00pm PT
Salvage Proton Therapy After Primary Cryosurgery or HIFU for Prostate Cancer
Speaker: Daniel Lichlyter, BS - Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville -
04:45pm - 06:00pm PT
Screening of the Population Benefiting from Postoperative Radiotherapy in Resectable Stage III-N2 NSCLC Patients Receiving Neoadjuvant Chemoimmunotherapy
Speaker: Min Li, - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan -
04:45pm - 06:00pm PT
Secondary Imaging Analysis of a Clinical Trial Combining SABR and PEF Ablation for Central Lung Tumors
Speaker: Nicholas Peterson, MD - UCI Radiation Oncology, Orange -
04:45pm - 06:00pm PT
Sexual Toxicity after Chemoradiation for Anal Cancer Among Men who have Sex with Men
Speaker: Beck Gold, BS - George Washington University School of Medicine, Washington -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Single-cell atlas and mechanistic study of lung adenocarcinoma with pulmonary sarcomatoid carcinoma
Speaker: Yuequn Ma, - Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan -
04:45pm - 06:00pm PT
Single-Fraction Lung SBRT for Primary and Metastatic Lung Tumors: Ten-Year Experience
Speaker: Luis Larrea, MD, PhD - Hospital Vithas Valencia Consuelo, Valencia -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Sociodemographic and Molecular Determinants of Disparities in NSCLC Outcomes: A Multi-Institutional Genomic Analysis
Speaker: Cesar Marquez, MD, PhD - MD Anderson Cancer Center, Houston -
04:45pm - 06:00pm PT
Sociodemographic Factors Associated with Proton Therapy Accessibility in NRG Oncology Trials of Locally Advanced NSCLC
Speaker: Bryan Johnson, MD, MBA - Mayo Clinic Florida, Jacksonville -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Stereotactic Radiosurgery for Recurrent Primary and Metastatic CNS Malignancies in the Pediatric Population
Speaker: Michael Gribble, MD - UCSF Radiation Oncology, San Francisco -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Study on the mechanism of ATF3 in regulating Radiation-Induced Lung Injury
Speaker: Yang Liu, - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, jinan -
04:45pm - 06:00pm PT
Survival Disparities In Lung Cancer Based On Tumor Staging And Demographics In A Third World Country Radiation Therapy Cohort
Speaker: Luísa Assunção, - 1. RadioSerra Radiation Therapy 2. Petropolis Medical School - FMP, Petrópolis -
04:45pm - 06:00pm PT
Targeting ADAM17 N-glycosylation Enhances Radiosensitivity in Non-Small Cell Lung Cancer via the NOTCH-ABCC1-ROS/cGAMP axis
Speaker: Ran Zhang, PhD - Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan -
04:45pm - 06:00pm PT
Targeting Educational Needs and Patient Reported Outcomes in Spanish-Speaking Latino/a Radiation Oncology Patients
Speaker: Oscar Padilla, MD - Mount Sinai Hospital, New York -
04:45pm - 06:00pm PT
Targeting Protein Kinase CK2 to Reprogram Phospholipid Metabolism and Enhance the Efficacy of Radioimmunotherapy in Lung Cancer
Speaker: Rui Meng, PhD - Department of Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan -
04:45pm - 06:00pm PT
The Changing Dogma in Oligometastatic Renal Cell Carcinoma - SBRT
Speaker: Papaiah Susheela Sridhar, MD - Healthcare Global Enterprises Ltd., Bangalore -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
The Impact of Effective Dose to Immune Cells and Platelet-to-Lymphocyte Ratio on Lymphopenia and Prognosis in Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer
Speaker: Haoting Yang, - Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical, Jinan -
04:45pm - 06:00pm PT
The Results of Re-Irradiation in Pediatric Recurrent Central Nervous System Tumors
Speaker: Ayca Iribas, MD - Istanbul University, Istanbul -
04:45pm - 06:00pm PT
The Role of Radiotherapy in Unresectable Primary Pulmonary Sarcoma: A Multicenter Study
Speaker: Ailing Liu, - Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan -
04:45pm - 06:00pm PT
Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer with Liver Metastases: A Multicenter Retrospective Evaluation of Survival Outcomes
Speaker: Xinyu Fan, - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan -
04:45pm - 06:00pm PT
Too Full to Fail? Impact of Excessive Bladder Filling on Patient Experience in Prostate Cancer Radiotherapy
Speaker: Luke Peng, MD, MS - Brigham and Womens/Dana Farber Cancer Institute, Boston -
04:45pm - 06:00pm PT
Topical Honeysuckle Flower Gel for Radiation Dermatitis: A Novel Approach to Prevention and Management
Speaker: Chin-Nan Chu, MD, PhD - Department of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan, R.O.C., Taichung -
04:45pm - 06:00pm PT
Toxicities of Brain and Spinal Cord Photon and Proton Radiation in Pediatric Brain Tumors Assessed by Real-World Data (RWD)
Speaker: Brandon Craig, MD, PhD - University of Calgary, Calgary -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Toxicity Profile for Connective Tissue Disease Patients Treated with Lung Stereotactic Body Radiation Therapy (SBRT)
Speaker: Adannia Ufondu, MD, BA - Cleveland Clinic, Cleveland -
04:45pm - 06:00pm PT
Transgender and Non-Binary Disparities: Discrimination Impact on Health-Related Quality of Life - All of Us Cancer Survivor Study
Speaker: Daniel Sabater Minarim, - University of California San Diego Health, San Diego -
04:45pm - 06:00pm PT
Treatment Approach in Childhood Ewing Sarcoma - TROD Hematology Oncology Pediatric Oncology Total Body Irradiation Working Group Survey Study
Speaker: Candan Demiroz, MD, RT - Uludag University Faculty of Medicine, Bursa -
04:45pm - 06:00pm PT
Treatment Interruptions in NSCLC Radiotherapy: Impact on Outcomes in a Statewide Quality Collaborative
Speaker: Ameer Elaimy, MD, PhD, BS - University of Michigan Health System, Ann Arbor -
04:45pm - 06:00pm PT
Treatment Outcomes of High-Dose Hypofractionated Palliative Radiotherapy (40 Gy in 10 daily fractions) for Non-Small Cell Lung Cancer
Speaker: James Chow, MBChB - Queen Elizabeth Hospital, Hong Kong -
04:45pm - 06:00pm PT
Treatment Strategy for Potentially Resectable Stage III-N2 Driver Gene-Negative NSCLC in the Immunotherapy Era
Speaker: Jiarui Zhao, - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan -
04:45pm - 06:00pm PT
Understanding Patient Priorities for Religious and Spiritual Needs during Radiotherapy for Gynecologic Malignancies
Speaker: Lauren Jacobs, MD - Mount Sinai Hospital, New York -
04:45pm - 06:00pm PT
Urinary Quality of Life Outcomes with Stereotactic Body Radiation Therapy Delivered Daily Compared to Every Other Day in Patients with Prostate Cancer
Speaker: Ramesh Gadam, MD, MBBS - University of Kansas Medical Center, Kansas City -
04:45pm - 06:00pm PT
USP10-Mediated Deubiquitination of FGL1 Drives Radioresistance in Lung Cancer by Stabilizing the Assembly of the Wnt5a Receptor Complex
Speaker: Xiaohua Jie, - Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan -
04:45pm - 06:00pm PT
USP10-Mediated PFKFB4 Deubiquitination Induces Lung Cancer Radioresistance by Activating the Fumaric Acid/Rad51 Axis
Speaker: Yunshang Chen, - Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan -
04:45pm - 06:00pm PT
Variation in Treatment Time and On-Board Imaging for Lung Tumors by Motion Management Technique: A Secondary Analysis of the iSABR Trial
Speaker: John Worth, - Stanford University, San Jose -
04:45pm - 06:00pm PT
Vertebral-Body-Sparing Proton Craniospinal Irradiation in Pediatric Patients: Spinal Growth and Acute Toxicity Outcomes
Speaker: Chuyu Xia, MD - Peking University First Hospital, Beijing -
04:45pm - 06:00pm PT
Voxel-Based Analysis of Cardiac Radiosensitivity: Impact of Consolidation Immunotherapy after Chemoradiotherapy
Speaker: Hong In Yoon, MD, PhD - Yonsei University Health System, Seoul -
04:45pm - 06:00pm PT
ZDHHC15 Mediated <em>S</em>-Palmitoylation of ENO1 Reprograms Glycometabolism to Confer Non-Small Cell Lung Cancer Radioresistance through Upregulating Ku70 and Ku80
Speaker: Zhiyuan Zhou, MD - Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan -
04:45pm - 06:00pm PT
Prospective, Longitudinal Assessment of Financial Toxicity and Emotional Well-Being for Women with Gynecologic Cancers Receiving Radiotherapy
Speaker: Michayla Brown, MS - University of Alabama at Birmingham, Birmingham